Skip to main content

Table 2 Prevalence of each component of high bleeding risk criteria

From: Post-discharge major bleeding/all-cause death in acute coronary syndrome: academic research consortium criteria versus Japan-specific criteria

Patients positive for ARC-HBR/J-HBR criteria

 ARC-HBR criteria, n (%)

450 (51)

 J-HBR criteria, n (%)

580 (65)

Major criteria (common in both the ARC-HBR and J-HBR)

 OAC use, n (%)

120 (13)

 Severe CKD, n (%)

66 (7)

 Severe anemia, n (%)

111 (12)

 Low platelet counts, n (%)

20 (2)

 Major bleeding history, n (%)

20 (2)

 Liver cirrhosis with portal hypertension, n (%)

5 (0.6)

 Active cancer, n (%)

37 (4)

 History of ICH/recent stroke/AVM, n (%)

26 (3)

 Major surgery under DAPT, n (%)

37 (4)

 Recent major trauma/surgery, n (%)

5 (0.6)

Major criteria (specific in the J-HBR)

 Frailty, n (%)

115 (13)

 Heart failure, n (%)

203 (23)

 Peripheral vascular disease, n (%)

97 (11)

Minor criteria (common in both the ARC-HBR and J-HBR)

 ≥ 75 years, n (%)

342 (38)

 Moderate CKD, n (%)

278 (31)

 Moderate anemia, n (%)

155 (18)

 Minor bleeding history, n (%)

4 (0.4)

 NSAIDS/steroids, n (%)

49 (5)

 Minor stroke, n (%)

75 (8)

  1. Categorical data are expressed as the percentage (%) and number
  2. ARC-HBR Academic Research Consortium-High Bleeding Risk, AVM arteriovenous malformation, CKD chronic kidney disease, DAPT dual antiplatelet therapy, ICH intracranial hemorrhage, J-HBR Japanese-High Bleeding Risk, NSAIDs Non-steroidal anti-inflammatory drugs, OAC oral anticoagulants